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N-linked glycosylation is a biologically important
protein modification, but only a small fraction of
modification sites have beenmapped.Wedeveloped
a ‘‘filter aided sample preparation’’ (FASP)-based
method in which glycopeptides are enriched by
binding to lectins on the top of a filter and mapped
6367 N-glycosylation sites on 2352 proteins in four
mouse tissues and blood plasma using high-accu-
racy mass spectrometry. We found 74% of known
mouse N-glycosites and discovered an additional
5753 sites on a diverse range of proteins. Sites
almost always have the N-!P-[SjT]-!P (where !P is
not proline) and rarely the N-X-Cmotif or nonconsen-
sus sequences. Combining the FASP approach with
analysis of subcellular glycosite localization reveals
that the sites always orient toward the extracellular
space or toward the lumen of ER, Golgi, lysosome,
or peroxisome. The N-glycoproteome contains
a plethora of modification sites on factors important
in development, organ-specific functions, and
disease.INTRODUCTION
N-glycosylation is one of the most prominent posttranslational
protein modifications and plays a major role in the assembly of
complex multicellular organs and organisms (Varki et al., 2009).
This modification is involved in many cellular functions including
cell-cell and receptor-ligand interactions, immune response,
apoptosis, and pathogenesis of many diseases (Varki et al.,
2009; Woods et al., 1994). N-glycosyltransferases are predomi-
nantly located in the lumen of the ER and Golgi apparatus and
attach this modification cotranslationally in a complex series of
processing steps to a subset of the sites with the consensus
sequence N-!P-[SjT] (where !P signifies any amino acid except
proline). This motif has been extended to N-!P-[SjT]-!P inC. elegans (Kaji et al., 2007). It is also possible that there are
consensus motifs different from the canonical one.
Because of the topological location of the transferases, the
modification is thought to be localized on secreted molecules,
the extracellular part of plasma membrane proteins, and the
lumenal part of proteins in compartments of subcellular
organelles such as the endoplasmatic reticulum and the Golgi
apparatus, endosomes, and lysosomes. A number of authors
have raised the possibility that N-linked glycosylation may also
be present in mitochondria (Chandra et al., 1998; Kung et al.,
2009), in the nucleus (Reeves et al., 1981), and in the cytoplasm
(Pedemonte et al., 1990). However, these studies do not map
residue-specific N-linked glycosylation sites.
Despite great biological and clinical interest, our knowledge of
in vivo N-glycosylation sites—a prerequisite for detailed
functional understanding—is still very limited. Liquid chromatog-
raphy coupled to high-resolution mass spectrometry (LC-MS)
has emerged as the key technology for large-scale analysis of
posttranslational modifications in general and N-glycosylated
proteins in particular (Aebersold and Mann, 2003; Jensen,
2006; Medzihradszky, 2005; Witze et al., 2007). The large
complexity of attached sugar molecules (North et al., 2010)
and the low expression levels of many N-glycoproteins make
the characterization of complete N-glycosylation structures
very challenging. To detect low abundant N-glycosylated
proteins or peptides in complex mixtures among the large
excess of their nonglycosylated counterparts, specific enrich-
ment methods have to be applied, most commonly based on
lectin affinity (Bunkenborg et al., 2004) or chemical linkage of
the sugar moiety to surfaces (Zhang et al., 2003). For determina-
tion of glycosylation sites—as opposed to the structure of the
sugar—a universal deglycosylating enzyme (i.e., PNGase F) is
used. This leads to deamidation of the asparagine residue to as-
partic acid and a mass increase of 0.9848 Da of the modification
site, which can be detected by tandemmass spectrometry (MS/
MS) as amass shift of the precursor peptide and of its fragments.
If deglycosylation is performed in 18O-water, the mass shift is
2.9890 Da, adding confidence to the site assignment (Kuster
and Mann, 1999).
Among large-scale N-glycoproteomic studies, the largest
reported 1495 N-glycosylation sites from C. elegans (Kaji et al.,Cell 141, 897–907, May 28, 2010 ª2010 Elsevier Inc. 897
2007). Others measured up to a few hundred N-glycosylation
sites on cell surface proteins of the immune system (Wollscheid
et al., 2009), of mouse C2C12 myoblasts (Gundry et al., 2009), in
human blood plasma (Liu et al., 2005), in human serum (Bunken-
borg et al., 2004), in human saliva (Ramachandran et al., 2006),
and in rat liver (Lee et al., 2009).
The data of large-scale proteomics studies and some directed
studies are combined in the Swiss-Prot database (Wu et al.,
2006), which results in 830 mouse and 1998 human N-glycosyl-
ation sites. This is likely a drastic underestimate of the true extent
of the mammalian N-glycoproteome. Notably, even though the
Swiss-Prot database presents the most comprehensive
resource of annotated N-glycosylation sites, it is not complete
because of the difficulty in retrieving single sites from numerous
literature studies.
Given its biomedical importance, we set out to map this modi-
fication in-depth andat very highaccuracy using recent advances
in proteomics technology.WehavedevelopedanN-glycopeptide
enrichment method based on ‘‘filter aided sample preparation’’
(FASP) (Wisniewski et al., 2009b), which allows highly efficient
capture of glycopeptides even from membrane proteins. We
employ the ability of the recently introduced LTQ-Orbitrap Velos
instrument to measure peptide fragments, and not only peptide
precursor masses, with low ppm mass accuracy and at high
sensitivity (Olsen et al., 2009). Our analysis of four differentmouse
tissues and blood plasma achieves very high confidence and
covers a substantial part of themouse N-glycoproteome—allow-
ing in-depth characterization of this protein modification.
RESULTS
Development of a FASP-Based N-linked Glycopeptide
Capture Method (N-Glyco-FASP)
Most N-linked glycosylations occur on membrane proteins,
which have traditionally been difficult to analyze by proteomic
methods.Wehave recently shown that the FASPmethod is espe-
cially well suited to analyze this class of proteins because it
achieves complete protein solubilization in SDS while still allow-
ing gel-free analysis (Wisniewski et al., 2009b). We reasoned that
FASP could be combined with peptide affinity capture simply by
adding the affinity reagent—in this case lectin—to the top of the
filter after on-filter protein digestion. Glycosylated peptides are
bound by lectin and thereby retained whereas nonglycosylated
peptides can be washed through the filter. Next, glycopeptides
are efficiently deglycosylated by PNGase F and released
peptides are eluted, resulting in a peptide population of high
purity (Figure 1A). We used two different endoproteinases,
trypsin and Glu-C, to increase the number and localization confi-
dence of glycosylation sites. In our experiments with the ‘‘N-
glyco-FASP’’ method, sample amounts were typically 200 mg of
total protein in 40ml, but this canbe scaled upor downasdesired.
To capture all three classes of N-glycosylated peptides, multi-
lectin enrichment can be employed (Yang and Hancock, 2004).
In N-glyco-FASP, lectins do not need to be coupled to a solid
support because they are retained by the filter, and therefore
any lectin or mixture of lectins can be employed. We selected
concanavalin A (ConA), which binds to mannose, wheat germ
agglutinin (WGA), which binds to sialic acid, as well as N-acetyl-898 Cell 141, 897–907, May 28, 2010 ª2010 Elsevier Inc.glucosamine and agglutinin RCA120, which captures galactose
modified at the 3-0 position (e.g., with sialic acid or another
galactose) as well as terminal galactose. Enrichment with this
mixture of lectins was as efficient as separate experiments
based on enrichment with all single lectins (Figure 1B). Overall,
63% of all N-glycosylation sites identified in a given tissue could
be detected in a single LC-MS/MS experiment by multi-lectin
enrichment. In comparison, 69% of a given tissue N-glycopro-
teome was covered when combining three LC-MS/MS experi-
ments based on single lectin enrichment. WGA proved to have
the highest binding efficiency among the applied lectins. The
proportion of glycosylated peptides—measured as deamidated
peptides after PNGase F digestion—to all identified peptides in
single run analysis was 46%. In our experiments, this is compa-
rable to or higher than the enrichment of phosphorylated
peptides (Macek et al., 2009) and substantially higher than the
enrichment of lysine acetylated peptides (Choudhary et al.,
2009). Without lectin enrichment, glycopeptides were 0.5% of
total peptides, indicating an enrichment factor of about 100-
fold (Figure 1C). We also interrogated our datasets for other
modifications but did not find large numbers of such peptides.
Precision Mapping of N-Glycosylation Sites
To identify deglycosylated peptides we used on-line liquid chro-
matography electrospray mass spectrometry (LC-MS/MS) on
the recently introduced linear ion trap orbitrap instrument
(LTQ-Orbitrap Velos). The LTQ-Orbitrap is capable of fragment-
ing peptides by ‘‘higher-energy dissociation’’ (HCD), in which the
fragment mass spectrum is analyzed in the high-resolution part
of the instrument without loss of low-mass ions (Olsen et al.,
2007). The superior sequencing capabilities of HCD compared
to ion trap fragmentation (CID) normally come at the cost of
reduced sensitivity. However, the Velos instrument features
20-fold improved HCD performance (Olsen et al., 2009). We
therefore tested if we could measure the N-glycosylation sites
with HCD without loss of sensitivity. Comparison of orbitrap
HCD and ion trap CID showed that HCD identified approximately
the same number of glycosylated peptides and that it did not
discriminate against low-abundance peptides (Figure S1 avail-
able online). We therefore performed all subsequent MS anal-
yses in high-resolution precursor and high-accuracy fragment
mode (‘‘high-high’’ strategy).
We applied N-glyco-FASP combined with high-high MS
measurement to four mouse organs (brain, liver, kidney, and
heart) and blood plasma, which we group together with the
other tissues for simplicity. Each tissue was independently
prepared in triplicates and measured 11 times by single LC-
MS/MS runs with 4 hr gradients after deglycosylation in 18O-
water by both single and multi-lectin enrichment. Furthermore
we measured N-glycosylation sites in four subcellular fractions
of liver cells. Together, 59 LC-MS/MS runs were acquired
(Table S1A). Additionally, we performed 64 experiments without
18O-water (Table S1B). Analysis of the data was performed with
the MaxQuant software (Cox and Mann, 2008) specifying a false
discovery rate of 1% at the peptide and site level. Average
absolute mass deviation was 0.57 ppm for identified peptides
and 3 ppm for all fragment ions contributing to peptide identi-
fication (Figure 2A). The median Mascot identification score for
Figure 1. Sample Preparation and Enrichment of N-Glycosylated Peptides: N-Glyco-FASP
(A) A standard filtration device with 30k molecular cut-off is used as a proteomic reactor. Whole SDS-lysates of mouse tissues are processed according to the
FASP protocol (a and b). To enrich for N-glycosylated peptides the digests are incubated with free lectins on the filter unit (c). Unbound peptides are removed by
centrifugation. The bound glycopeptides are deglycosylated with PNGase F (d), eluted from the filter (e), and identified using high-accuracy LC-MS/MS. Peptide
ions are fragmented via higher-energy dissociation (HCD).
(B) The proportion of N-glycosylated sites identified in a single LC-MS/MS experiment was lower in the case of single-lectin enrichment (ConA, RCA120, WGA)
compared to multi-lectin enrichment. Using amixture of lectins in one LC-MS/MS run was nearly as efficient as combining single lectin enrichment-based exper-
iments in three LC-MS/MS runs.
(C) The proportion of detected N-glycosylated to unmodified peptides in an experiment without enrichment was 0.5%. With N-glycosylation enrichment the
proportion increased by a factor of about 100 (to a median of 46%).
See also Table S1 and Table S2.glycopeptides was 65 (Perkins et al., 1999) and the median
posttranslational modification (PTM) score was 112 (Olsen
et al., 2006) (Figures 2B and 2C). Because neither Mascot nor
PTM scores incorporate the high fragment mass accuracy
into database identification scores, confidence of glycopep-
tides identification is much higher than even those scores indi-
cate. The average localization probability of all identified sites
was 94.92%. This indicates that both peptide identification
and localization of the modification in the peptide sequence
with single amino acid resolution were unambiguous. Out of
all identified N-glycosylated sites, we derived those that had
a minimum residue localization probability of 95% and that
were identified in two or more experiments with a minimum
of one confirmation in the 18O-water experiment to build
a top confidence (class I) set (Table S2A). N-glycosites that
do not satisfy these extremely strict criteria but show a residue
localization probability higher than 90% are also high-confi-
dence sites (class II, Table S2B), but they were not included
in the global analyses described in this paper. Average localiza-
tion probability of class I and II sites was 99.97%.We performed PNGase digestion both with and without 18O-
water (see Extended Experimental Procedures). As mentioned
above, 18O-water deglycosylation events lead to a mass incre-
ment of 2.9890 Da that can be readily distinguished from spon-
taneous deamidation (mass increment of 0.9858 Da). Therefore
the experimental confirmation with 18O-water was considered
as criteria for the definition of our top confidence set as
described above. An example spectrum for N-glycopeptide
identification is shown in Figure 2D.
The In Vivo Mouse N-Glycoproteome
Our large-scale analysis resulted in the high-confidence identifi-
cation of 6367N-glycosylated sites with a localization probability
higher than 90%on2352proteins (class I and II; Table S2; all sites
are available in the PHOSIDA database along with their corre-
sponding spectra; Gnad et al., 2007). This dataset covers 74%
of the 830 experimentally derived mouse N-glycosites recorded
in Swiss-Prot (Version 57.12). Overall, 5753 sites of our set
were not previously recorded as experimentally identified.
Swiss-Prot also contains a largenumber of potential N-glycositesCell 141, 897–907, May 28, 2010 ª2010 Elsevier Inc. 899
Figure 2. Identification of the Glycosylation Sites by High-Accuracy Tandem Mass Spectrometry using HCD Fragmentation
Distribution of MS/MS mass deviations (A), Mascot scores (B), and PTM scores (C) of the sequenced deglycosylated peptides.
(D) Representative MS/MS spectrum of the peptide WEGELGTDLVSIPHGPNVTVR of b-secretase 1, identified in 18O-water. The mass increment of 2.9890 Da is
indicated.
See also Figure S1.(11,846), partly by similarity to the 1998 known human sites but
mainly derived from bioinformatic prediction. Of these sites, we
cover 33%,which is excellent agreement given the fact that algo-
rithms are generally adjusted toward overprediction.
Several lines of experimental evidence suggest that our data-
set achieves very deep coverage of the mouse N-glycopro-
teome: Technical and biological repeats of N-glyco-FASP
enriched tissue samples resulted in largely overlapping N-gly-
cosites (on average 80% between any two single runs) and
added only a small number of additional sites (Figure 3A).
Additional fractionation either on the protein level by size-exclu-
sion chromatography (Zielinska et al., 2009) or on the peptide
level by anion exchange chromatography (Wisniewski et al.,
2009a) resulted in only a few percent of additional glycosites.
In contrast, performing these additional fractionation steps for
the tissue proteome more than doubled the number of detected
proteins compared to a single run (Figure 3B). Both observa-
tions are consistent with a glycoproteome that is thoroughly
sampled by our analysis.
Sequence Recognition Motifs, Structure Preference,
and Occupancy
The canonical N-linked glycosylation motif is N-!P-[SjT]. We
reasoned that our high precision and large-scale dataset might900 Cell 141, 897–907, May 28, 2010 ª2010 Elsevier Inc.provide a good basis to test the generality of this motif and to
discover further consensus sequences. We compared the posi-
tion-specific amino acid frequencies of the surrounding
sequences (six amino acids to both termini) of glycosylated
asparagines that have serine or threonine on the second position
to the C terminus with those of all asparagines that occur in the
mouse proteome. We found that proline is drastically underrep-
resented not only in the first position relative to the modification
site (0% compared to 6.16% expected) but also in the third posi-
tion (0.54% compared to 5.16% expected; p = 0; Table S3A).
Notably, cysteine was highly enriched in the surrounding
sequences of N-glycosites that match with the canonical
N-!P-[SjT] motif. Threonine occurs more frequently (1.4-fold)
than serine at the second position—the reverse proportion as
in the surrounding sequences of nonglycosylated asparagines
that match with the consensus motif.
Next we asked if there were any motifs different from the
canonical one. We applied the de novo method Motif-X
(Schwartz and Gygi, 2005) to the surrounding sequences of
all top confidence N-glycosylated asparagines (Extended
Experimental Procedures). This resulted in the identification of
three further significantly overrepresented consensus
sequences (Figure 4A). Of 5052 sites, 177 did not match the
N-!P-[SjT] motif. These sites turned out to be heavily enriched
Figure 3. Depth of the Detected N-Glycoproteome
(A) Repeated measurements of each tissue yielded a minimal increase of identified N-glycosylation sites.
(B) Fractionationmethods such as size-exclusion chromatography (SEC) and anion-exchange chromatography (SAX) did not result in a greatly increased number
of identified N-glycosites, whereas the number of detected proteins in a proteome measurement increased more than 2-fold.for cysteine or valine in place of S/T. In addition, glycine was
enriched on the first position toward the C terminus. This result
is interesting, as no other motifs except for N-!P-[SjT] and
anecdotal evidence for the N-X-C motif are known (Zajonc
et al., 2008). Overall, 112 N-glycosylated sites do not matchFigure 4. Sequence Recognition Motifs, Structure Preference, and Mu
(A) N-glycosylation consensus sequence as derived using MotifX. WebLogo (Sc
most significant sequence motif is the canonical one, with serine and threonine
N-G, and N-X-V were statistically identified.
(B) Proportion of N-glycosylated and non-N-glycosylated asparagines localized
(C) Distribution of singly and multiply glycosylated proteins.
See also Figure S2 and Table S3.with any of the consensus sequences. To further verify the exis-
tence of N-glycosylation on sites that do not match with the
known motifs, we performed western blotting on Apolipopro-
tein A1 (ApoA1) and Apolipoprotein E (ApoE) (Extended Exper-
imental Procedures). In our large-scale dataset we found bothltiple Glycosylation
hneider and Stephens, 1990) was used to create relative frequency plots. The
on position 2. In following iterative steps the consensus sequences N-X-C,
in loops, a helices, and b sheets.
Cell 141, 897–907, May 28, 2010 ª2010 Elsevier Inc. 901
Figure 5. Gene Ontology Analysis
Cellular components (A) and molecular functions and biological processes (B)
that are significantly overrepresented in the N-glycoproteome compared to the
entire mouse proteome, according to Gene Ontology analysis. See also Table
S4 and Table S5.proteins to be N-glycosylated (ApoA1 on position 66, ApoE on
position 130), even though they do not contain any asparagines
that match with N-!P-[SjT] or N-X-C. In western blots, both
proteins shifted their apparent molecular weights after PNGase
treatment (Figure S2).
We predicted the secondary structure localizations and
solvent accessibilities of N-glycosylated and non-N-glycosy-
lated asparagines of N-linked mouse glycoproteins with SABLE
2.0 (Wagner et al., 2005) (Extended Experimental Procedures).
As expected, N-glycosites are enriched on the protein surface.
Like their unmodified counterparts N-glycosylated sites are
mainly located in loop structures (71% versus 75%). Strikingly,
we found evidence for a highly significant enrichment
(p < 1010) in b sheets in comparison to non-N-glycosylated
asparagines. Overall, 15% of glycosylated asparagines are pre-
dicted to be localized in b sheet structures in comparison to 5%
of nonglycosylated asparagines (Figure 4B).
The percentage of proteins modified at a particular site (‘‘site
occupancy’’ or ‘‘stoichiometry’’) is often very low for reversible
PTMs. N-glycosylation is thought to be stable and frequently
serves structural roles, which would favor high site occupancy.
Studies in the literature frequently report high N-glycosylation
site occupancy. For example, transferrin and a1-antitrypsin
showed 98%–100% occupancy in human serum (Hulsmeier
et al., 2007). However, experimental evidence for incomplete
occupancies has also been reported. For example, in mouse
brain the major prion protein has two different N-glycosylation
sites with incomplete occupancy (66% of proteins glycosylated
on both sites, 14% on one site, and 20% nonglycosylated)
(Bradford et al., 2009).
If glycosylation mainly occurred in high stoichiometry, then the
nonmodified counterparts of the brain N-glycopeptides should
rarely be detected. In a separately measured brain proteome,
we found that 98.6% of 2714 N-linked glycosylated peptides
were not present in their unmodified form among 33,198 identi-
fied peptides. The lack of such peptides suggests high occu-
pancy of glycosylation sites.
Of the total of 1938 N-glycosylated proteins from the top
confidence set, approximately half carried a single N-linked
sugar chain (Figure 4C). For 22% we detected two N-glycosyl-
ation sites, 13% carried three identified sites, and the average
degree of glycosylation was 2.6. Notably, there was a group
of 247 proteins that contained 5 or more N-glycosylation sites
and 44 with at least 10. Low-density lipoprotein receptor-
related protein I and II were the most heavily glycosylated
proteins with 41 and 32 asparagine-linked glycosylation sites,
respectively.
We applied cluster analysis to test whether N-glycosites occur
in specific sequence segments of the proteins or whether they
are randomly distributed on the primary sequence (Extended
Experimental Procedures). Bootstrapping-based comparison
of primary sequence distances between N-glycosylated and
non-N-glycosylated asparagines of multiply glycosylated
proteins did not reveal significant differences (Table S3B).
Instead, the sites in some proteins such as sortilin (858 residues;
N160, N272, N404, N682) are evenly distributed over the
sequence, whereas they tightly cluster in other proteins such
as Latrophilin-1 (1466 residues; N526, N635, N736, N795, N800).902 Cell 141, 897–907, May 28, 2010 ª2010 Elsevier Inc.Cellular and Functional Classification of N-Glycosylated
Proteins
We wished to obtain an overview of the subcellular compart-
ments and the cellular functions that N-linked glycoproteins
are preferentially associated with. We applied Cytoscape
(Shannon et al., 2003) and BinGO (Maere et al., 2005) to
determine Gene Ontology (GO) categories overrepresented in
the glycoproteome compared to the entire mouse proteome.
A total of 31% of the N-linked glycoproteome was in the
‘‘plasma membrane’’ GO category and 25% in ‘‘extracellular
region’’ (Table S4A). Taking into account nonexclusive localiza-
tion in GO, 52%of the N-glycoproteome is located at the outside
or beyond the plasma membrane (832 of 1594 N-glycoproteins
with GO annotation). Furthermore, the ER, the Golgi apparatus,
and the lysosome are overrepresented (Figure 5A). We also
found N-glycosylated proteins associated with the peroxisome,
endosome, and vacuole. Together, these intralumenal locations
of cellular organelles accounted for 20%of theN-glycoproteome
with GO annotation. Intriguingly, a number of proteins were as-
signed to compartments that are not topologically connected
with the lumen of the ER or Golgi. However, in almost all cases,
these annotations were nonexclusive or they were different in
other databases such as Ensembl.
To directly address the long-standing question of N-glycosyl-
ation in unexpected cell compartments, we applied subcellular
Figure 6. N-Glycoproteomes of Different Mouse Tissues
Number of identified N-glycosylated sites in blood plasma, brain, kidney, liver,
and heart. Sites detected in blood plasma are in orange. Gray: sites only de-
tected in one organ; purple: sites detected in at least two organs. See also
Figure S3 and Table S6.fractionation to mouse liver using sucrose gradient separation
(Extended Experimental Procedures). Consistent with the
above results, we did not find any N-glycosites in proteins
that were annotated on the basis of experimental evidence to
be localized exclusively in the nucleus, in the mitochondria, or
in the cytosol.
Within the set of plasma membrane proteins, 99% of 912 N-
glycosylated sites were located in the extracellular region based
on predicted Swiss-Prot topology assignments. Our dataset
contains five examples of N-glycosylation, annotated to occur
in cytoplasmic domains (Table S4B). However, each of these
topology assignments was based on bioinformatic prediction
rather than experimental evidence. Given the uncertainties of
such predictions and the fact that only 5 out of 912 sites were
mapped to an unexpected topological location, we conclude
that our dataset contains no statistically significant evidence
for N-glycosylation on the cytoplasmic face of proteins.
Many functions that are known to be characteristic for N-
glycoproteins were enriched in our set, including transporter
activity, receptor activity, and carbohydrate binding (Figure 5B,
Table S4C). Cell adhesion, response to external stimuli, and
multicellular organismal processes were the major overrepre-
sented biological processes (Figure 5B, Table S4D). Most of
the functional categories appear to be secondary to the location
of the proteins at the membrane. For example, ‘‘transmembrane
protein tyrosine kinase activity’’ is significantly overrepresented
(p < 1022).
To test the robustness of our bioinformatic enrichment anal-
ysis, we repeated it by matching only the brain N-glycoproteome
against the brain proteome derived as part of this study (5880
proteins). We obtained very similar results, indicating that the
results are not tissue specific nor affected by using the total pro-
teome instead of tissue proteome as background (Table S4E).
KEGG pathway enrichment analysis (Kanehisa and Goto,
2000) using DAVID (Dennis et al., 2003) led to similar results
and additionally revealed that our N-glycoproteome is enriched
for proteins that are involved in neurodegenerative diseases
such as Alzheimer’s and prion disease (Table S5).
Tissue Distribution of the N-Glycoproteome
The function and extent of N-linked glycosylation are likely to be
different between the tissues. To investigate this issue, we sepa-
rately analyzed and overlapped the N-glycosites according to
the tissue in which they had been identified.
The blood plasma N-glycoproteome comprised 1119 sites.
According to GO annotation, they overwhelmingly mapped to
‘‘extracellular space’’ with only a few sites from lumenal organel-
lar localizations. As blood is present in all tissues—even after
perfusion of mice, as done here—sites that were identified in
both blood plasma and another tissue cannot be unambiguously
assigned to one of the tissues (marked in orange in Figure 6).
The highest number of N-glycosylation sites (3162) was
observed in brain. Of these, 1140 were not identified in any other
tissue and this group includes many brain-specific proteins.
Heart had the lowest number of identified sites (2213 total and
93 exclusive). All tissues had a large proportion of N-glycosyla-
tion sites that were found in at least one other tissue (purple in
Figure 6).Accurate Relative Quantification of the In Vivo
N-Glycoproteome
To demonstrate the capability of our approach to quantify N-gly-
coproteome changes under different conditions in vivo, we
applied stable isotope labeling of amino acids in cell culture (SI-
LAC) (Ong et al., 2002). Using brains from non-SILAC and SILAC
mice (Kruger et al., 2008) we compared the N-glycosylation site
pattern in old versus young mice (Extended Experimental
Procedures). We performed two independent experiments,
using different proteolytic enzymes, and each experiment was
repeated after swapping the SILAC labels between old and
young mice. We quantified 763 N-glycosylation sites using
LysC and 1118 N-glycosylation sites using trypsin. In both sets
we found the sameN-glycosylation sites to be under- or overrep-
resented in forward and reverse experiments (Figure S3A,
Table S6A). To determine if the apparent glycosylation changes
were instead due to changes in protein abundance, we also
quantified the brain proteins between the mice. Indeed, we
found that the detected regulations occur not on the site but at
the protein level (Table S6B and Table S6C). Although these
experiments do not exclude subtle changes between the N-
glycoproteome as a function of age, they suggest that there
are no drastic changes. They also demonstrate that the N-
glyco-FASP method is fully compatible with accurate SILAC-
based quantification.Evolution of N-Glycosylation
To derive orthologous proteins in 36 eukaryotic species, we
assigned N-glycosylated proteins to their corresponding gene
entries in Ensembl (Flicek et al., 2008; Gnad et al., 2009) and
retrieved evolutionary annotation data from the Ensembl
Compara Database (Vilella et al., 2009). We defined only ‘‘one-
to-one’’ orthologs as interspecies homologs in our analysis.
This strict definition excludes between-species paralogs and
‘‘one-to-many’’ or ‘‘many-to-many’’ orthologs in the homology
set. Mouse N-glycoproteins have more orthologs in vertebrates
compared to all mouse proteins (Figure S3B). However, in
contrast to acetylated and phosphorylated proteins (Choudhary
et al., 2009; Gnad et al., 2007), mouse N-glycosylated proteins
have less orthologs in invertebrates and yeast. For example,Cell 141, 897–907, May 28, 2010 ª2010 Elsevier Inc. 903
8% of mouse N-glycoproteins have orthologs in fly in compar-
ison to 14% non-N-glycosylated mouse proteins. This finding
also held true for each tissue-specific N-glycoproteome and
may reflect the specific functions of many N-glycosylated
proteins in multicellular organisms. Consistent with the drop in
conservation to lower organisms, only 32 of the 829 N-
glycosylated proteins identified in aC. elegansN-glycoproteome
(Kaji et al., 2007) had one-to-one orthologs in our mouse N-gly-
cosets. Finally, as expected, N-glycoproteins were not signifi-
cantly conserved to prokaryotes compared to the entire
proteome, as assessed by BLAST-based conservation analysis
(Figure S3C).
DISCUSSION
A Proteomic Approach for In-Depth Mapping
of the In Vivo N-Glycoproteome
We have developed and applied a strategy based on FASP,
multi-lectin affinity, and high-accuracy mass spectrometric
characterization. The N-glyco-FASP method allowed the deter-
mination of over 6000 N-glycosylation sites from five mouse
tissues. In single LC-MS/MS runs it is possible to map over
2000 sites from 200 mg starting material, which opens up inter-
esting areas of application. Enrichment efficiency is reflected
by the detection of more than 1000 N-glycosites on almost 500
proteins in blood plasma—thus N-glyco-FASP may be an
efficient method for plasma proteome characterization in
a biomarker context (Zhang et al., 2005). Importantly, the difficult
class of membrane proteins, on which most N-glycosylation
occurs, was excellently covered in our dataset due to the use
of SDS solubilization in the FASP protocol. Further highlighting
the deep coverage of the brain N-glycoproteome, we found
that 58% of 1296 identified N-glycoproteins were not contained
in our brain proteome consisting of 5880 proteins. Although
demonstrated for multi-lectin affinity here, the method is equally
applicable to the enrichment of other modified peptides. For
example, phosphotyrosine peptides could be enriched with
a mixture of anti-phosphotyrosine antibodies, which would not
have to be coupled to any support.
The data in our study were acquired with the LTQ-Orbitrap Ve-
los mass spectrometer with which peptide ions can be efficiently
and sensitively fragmented via HCD (Olsen et al., 2009). Mass
accuracy for fragments was in the low ppm range, about a factor
100 better thanwhat we achieved in recent large-scale studies of
the phosphoproteome and the acetylome (Choudhary et al.,
2009; Olsen et al., 2006). Thus a ‘‘high high’’ strategy with HCD
is a powerful technology for in-depth posttranslational modifica-
tion identification, as it allows very high-confidence identification
of individual peptides and ensures precise localization of modifi-
cations within the peptide sequence.
N-Glycoproteome Characterization
Our dataset covers 74% of all known mouse N-glycosylation
sites and increases the number of all experimentally identified
N-glycosites by a factor of about seven compared to the
Swiss-Prot reference database. Interestingly, the number of
identified N-glycosylation sites does not increase significantly
with repeated measurements and additional fractionation, sug-904 Cell 141, 897–907, May 28, 2010 ª2010 Elsevier Inc.gesting that our dataset covers a substantial part of the mouse
N-glycoproteome. This is in contrast to phosphoproteome
analysis, in which repeated runs and fractionation add a large
percentage of additional sites. Detection of 2352 N-linked glyco-
proteins demonstrates that more than 10% of the mouse
proteome is N-glycosylated. The fact that glycosylated peptides
are rarely found in their unmodified form points to high site
occupancy (stoichiometry). In contrast, phosphorylation and
acetylation are generally attached to the proteins in a substoi-
chiometric manner, and nonmodified counterparts can be found
for a large proportion of the phosphopeptides in proteomics
studies (Olsen et al., 2010).Biology and Evolution of the N-Glycoproteome
We find N-glycosites to be predominantly located in loops and
turns on the protein surface, similarly to what we previously
found for phosphorylation or acetylation sites (Choudhary
et al., 2009; Gnad et al., 2007). However, unlike either acetylation
sites or phosphorylation sites, N-glycosylation is also preferen-
tially located in b sheets. This points to a more stable and rigid
binding of cotranslationally attached sugar molecules in contrast
to reversible phosphorylation for which sites have to be acces-
sible posttranslationally to kinases and phosphatases.
Besides such structural constraints, the vast majority (96.5%)
of N-glycosylated asparagines match the stringent glycosylation
consensus sequence N-!P-[SjT]. Sequence motif analysis
reveals additional constraints on the known sequence recogni-
tion pattern. We find that proline is also underrepresented on
the third position relative to the asparagines. This has already
been shown inC. elegans (Kaji et al., 2007) but not in vertebrates.
Threonine occurs more often than serine on the second position,
in contrast to nonglycosylated sites that match the motif by
chance and to phosphorylation sites, which occur much more
often on serine than threonine. Furthermore, there are scattered
reports of N-X-C motif on individual proteins. Our results show
that this motif is widespread but that it occurs with a low
frequency of about 1.3%. Furthermore, 2.2% of the N-glycosites
did not match with either of the two motifs. We found these sites
to be enriched for either valine on the second position or glycine
on the first position relative to the N-glycosylated asparagine.
The N-G and N-X-V sequence overrepresentation is statistically
significant (Figure 4), and it will be interesting to investigate if it
represents further minor motifs for the N-glycosylation
machinery. Additionally, western blotting validated the occur-
rence of N-glycosylation on sites that do not match with the
known motifs (Figure S2). Thus our study provides in silico as
well as experimental evidence for N-glycosylation on consensus
sequences different from N-!P-[SjT] and N-X-C.
Evolutionary analysis reveals that N-glycosylated mouse
proteins are more highly conserved throughout vertebrates but
not invertebrates compared to non-N-glycosylated mouse
proteins. This finding underlines the essential role of N-glycosyl-
ation on proteins that evolved with the rise of vertebrates, in
concordance with the role of N-glycosylation in complex multi-
cellular organisms. In particular, the adaptive immune system
evolved in vertebrates and is thought to be intimately connected
with recognition glycostructures by host and pathogen,
providing a further reason why N-glycoproteins are more highly
conserved than their nonglycosylated counterparts.
Cellular Organization of N-Glycosylation
We almost exclusively found N-glycosylation to occur on
secreted molecules, on the extracellular face of membrane
proteins, and on the lumenal side of ER, Golgi apparatus, or
lysosomes. This is in agreement with the topology of glycosyl-
transferases that attach the sugar chains and usually have their
active sites within the lumens of the ER and Golgi.
There have been suggestions regarding the presence of N-gly-
cosylated proteins in the nuclear, cytoplasmatic, and mitochon-
drial compartments for many years (Pedemonte et al., 1990;
Reeves et al., 1981; Chandra et al., 1998; Kung et al., 2009).
Several experimental and conceptual attempts have been
undertaken to explain and prove this hypothesis. Nonconven-
tional soluble glycosyltransferases may exist in the cytoplasm
or nucleus and directly modify the proteins in these compart-
ment, or soluble N-glycosylated proteins may be flipped across
membranes or originate from secretory pathways (Varki et al.,
2009). Experimental evidence for such mechanisms was mostly
based on protein binding to lectins or radioactive labeling but did
not include mapping of the sugar attachment sites. For example,
sodium/potassium-transporting ATPase subunit alpha from dog
kidney was reported to contain N-glycan in its cytoplasmatic
domain but without defining the sites (Pedemonte et al., 1990).
Here, we detected a few N-glycosylation sites on parts of the
proteins sequence that were annotated as cytoplasmic domains
of plasma membrane proteins; however the topology of these
proteins is based on prediction methods. Therefore this
observation does not supply experimental evidence for the pres-
ence of N-glycosylation in the cytoplasm. Instead, despite in-
depth mapping of these cellular compartments, we did not
detect any proteins that were annotated to occur exclusively in
the nucleus, in the mitochondria, or in the cytosol. In summary,
our data point to a universal requirement of N-glycosylation sites
to be in topological continuity with the lumen of the ER andGolgi.
Tissue-Specific and Disease-Related N-linked
Glycoproteins
Many novel glycosylation sites have been detected for tissue-
specific proteins, such as neurotransmitter receptors and con-
tactins for brain or cubilin and megalin for kidney. For example,
we found 30 kidney-specific sites on megalin (low-density lipo-
protein receptor-related protein 2, 520 kDa), out of which only
one was reported in a recent N-glycoproteomic study
(Wollscheid et al., 2009).
Besides tissue-specific N-glycosylation sites, we also de-
tected a number of N-glycoproteins that are associated with
various diseases. For example, we found many N-glycosites
on proteins that are involved in Alzheimer’s disease (AD), the
most common type of dementia (Price et al., 1998). Because
N-glycosylation is involved in many processes impaired in AD,
such as protein folding, protein anchoring to cell membranes,
and protein delivery to organelles, it is possible that N-glycosyl-
ation is directly involved in cause or progress of AD (Selkoe,
2004; Suzuki et al., 2006). Surprisingly, using both high-accuracy
mass spectrometry and western blotting, we found N-glycosyla-tion on Apolipoprotein E, an important AD protein (Kim et al.,
2009), which does not contain any asparagines that match the
known motifs N-!P-[SjTj and N-X-C.Summary and Outlook
Here we provide a practical and highly efficient method for
mapping the attachment sites of N-glycostructures. Modification
sites occur on many proteins of pivotal importance in develop-
ment, multicellular communication, and many other basic
biological functions. These high-confidence N-glycosylation
sites can now be used by the community for detailed functional
studies. We have also shown that N-glyco-FASP is fully compat-
ible with quantitative proteomics methods such as SILAC, which
could be used to study the many diseases that directly or
indirectly involve N-glycosylation.EXPERIMENTAL PROCEDURES
Tissue Preparation, Protein Extraction, and Digestion
Tissues used in our study were dissected from inbred mouse strain C57BL/6,
males, aged 3 months and proceeded according to the FASP protocol (Wis-
niewski et al., 2009b). The resulting peptides were eluted in lectin binding
buffer (1 mM CaCl2, 1 mM MnCl2, 0.5 M NaCl in 20 mM TrisHCl, pH 7.3). For
more details, see the Extended Experimental Procedures.
Lectin Enrichment and Deglycosylation
Approximately 100 mg of digested peptides were mixed with lectin solution
containing either a combination of ConA, WGA, and RCA120 (Sigma) or just
one lectin at a time, resulting in mixtures of peptides and lectins with a mass
proportion of 1:2. The mixtures were transferred to new YM-30 filter units
(Microcon, Millipore). After 1 hr incubation at room temperature the unbound
peptides were eluted by centrifugation. The captured peptides were washed
followed by deglycosylation with PNGase F (Roche). After incubation for 3 hr
at 37C deglycosylated peptides were eluted. A more detailed protocol is
available in the Extended Experimental Procedures section.
Mass Spectrometric Analysis
The eluted peptides were purified on StageTips (Rappsilber et al., 2003) and
analyzed on the LTQ-Orbitrap Velos mass spectrometer; (Thermo Fisher
Scientific, Germany) coupled to HPLC via a nanoelectrospray ion source.
Full MS scans were acquired with resolution of 30,000 at m/z 400 in the
orbitrap analyzer. The ten most intense ions were fragmented by higher-
energy collisional dissociation (HCD) in the octopole collision cell. The HCD
fragment ion spectra were acquired in the orbitrap analyzer with resolution
of 7500 at m/z 400. The MS data were analyzed using MaxQuant (Cox and
Mann, 2008). Proteins were identified by searching MS andMS/MS data using
theMASCOT search engine (Matrix Science, UK) (Perkins et al., 1999). See the
Extended Experimental Procedures for further information.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, three
figures, and six tables and can be foundwith this article online at doi:10.1016/j.
cell.2010.04.012.
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